Cargando…
The role of serum calprotectin as a novel biomarker in inflammatory bowel diseases: a review study
As the incidence of inflammatory bowel diseases (IBD) increases in the newly industrialized countries, the health and financial burden of disease also increase. These changes make the role of IBD biomarkers further crucial. Serum calprotectin, as a novel blood-based biomarker of IBD, has been invest...
Autores principales: | Azramezani Kopi, Tayebeh, Shahrokh, Shabnam, Mirzaei, Shahrokh, Asadzadeh Aghdaei, Hamid, Amini Kadijani, Azade |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Shaheed Beheshti University of Medical Sciences
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668766/ https://www.ncbi.nlm.nih.gov/pubmed/31528300 |
Ejemplares similares
-
Inducible nitric oxide synthase as a potential blood-based biomarker in inflammatory bowel diseases
por: Baranipour, Saeed, et al.
Publicado: (2018) -
Transmembrane TNF-α Density, but not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
por: Amini Kadijani, Azade, et al.
Publicado: (2017) -
Erratum: Transmembrane TNF-α Density, But Not Soluble TNF-α Level, is Associated with Primary Response to Infliximab in Inflammatory Bowel Disease
por: Amini Kadijani, Azade, et al.
Publicado: (2017) -
Apoptosis markers of circulating leukocytes are associated with the clinical course of inflammatory bowel disease
por: Amini Kadijani, Azade, et al.
Publicado: (2018) -
Novel cell-based therapies in inflammatory bowel diseases: the established concept, promising results
por: Hossein-khannazer, Nikoo, et al.
Publicado: (2021)